Literature DB >> 34207918

Neutrophil-to-Lymphocyte Ratio and Early Variation of NLR to Predict In-Hospital Mortality and Severity in ED Patients with SARS-CoV-2 Infection.

Laure Abensur Vuillaume1, Pierrick Le Borgne2,3, Karine Alamé2, François Lefebvre4, Lise Bérard5, Nicolas Delmas6, Lauriane Cipolat1, Stéphane Gennai7, Pascal Bilbault2,3, Charles-Eric Lavoignet8.   

Abstract

(1) Introduction: The neutrophil-to lymphocyte ratio is valued as a predictive marker in several inflammatory diseases. For example, an increasing NLR is a risk factor of mortality in sepsis. It also appears to be helpful in other settings such as cancer. The aim of our work was to study the prognostic value of NLR for disease severity and mortality in patients infected with SARS-CoV-2 upon their admission to the Emergency Department (ED) and its early variation (ΔNLR) in the first 24 h of management (H-24). (2)
Methods: Between 1 March and 30 April 2020, we conducted a multicenter and retrospective cohort study of patients with moderate or severe coronavirus disease 19 (COVID-19), who were all hospitalized after presenting to the ED. (3)
Results: A total of 1035 patients were included in our study. Factors associated with infection severity were C-reactive protein level (OR: 1.007, CI 95%: [1.005-1.010], p < 0.001), NLR at H-24 (OR: 1.117, CI 95%: [1.060-1.176], p < 0.001), and ΔNLR (OR: 1.877, CI 95%: [1.160-3.036], p: 0.01). The best threshold of ΔNLR to predict the severity of infection was 0.222 (sensitivity 56.1%, specificity 68.3%). In multivariate analysis, the only biochemical factor significantly associated with mortality was again ΔNLR (OR: 2.142, CI 95%: ([1.132-4.056], p: 0.019). The best threshold of ΔNLR to predict mortality was 0.411 (sensitivity 53.3%; specificity 67.3%). (4)
Conclusion: The NLR and its early variation (ΔNLR) could help physicians predict both severity and mortality associated with SARS-CoV-2 infection, hence contributing to optimized patient management (accurate triage and treatment).

Entities:  

Keywords:  COVID-19; NLR; mortality; severity

Year:  2021        PMID: 34207918     DOI: 10.3390/jcm10122563

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  3 in total

Review 1.  High-value laboratory testing for hospitalized COVID-19 patients: a review.

Authors:  Daniela Cihakova; Michael B Streiff; Steven P Menez; Teresa K Chen; Nisha A Gilotra; Erin D Michos; Kieren A Marr; Andrew H Karaba; Matthew L Robinson; Paul W Blair; Maria V Dioverti; Wendy S Post; Andrea L Cox; Annukka A R Antar
Journal:  Future Virol       Date:  2021-09-21       Impact factor: 3.015

2.  Neutrophil-to-Lymphocyte Ratio (NLR) Is a Promising Predictor of Mortality and Admission to Intensive Care Unit of COVID-19 Patients.

Authors:  Matteo Regolo; Mauro Vaccaro; Alessandra Sorce; Benedetta Stancanelli; Michele Colaci; Giuseppe Natoli; Mario Russo; Innocenza Alessandria; Massimo Motta; Nicola Santangelo; Letizia Fiorito; Ornella Giarrusso; Federica Giangreco; Andrea Arena; Paola Noto; Claudio Ciampi; Giuseppe Carpinteri; Lorenzo Malatino
Journal:  J Clin Med       Date:  2022-04-16       Impact factor: 4.964

3.  Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Patients with COVID-19.

Authors:  Daniele Piovani; Andreas G Tsantes; Stefanos Bonovas
Journal:  J Clin Med       Date:  2022-08-11       Impact factor: 4.964

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.